vs

Side-by-side financial comparison of ASGN Inc (ASGN) and Invesco (IVZ). Click either name above to swap in a different company.

Invesco is the larger business by last-quarter revenue ($1.7B vs $970.0M, roughly 1.7× ASGN Inc). ASGN Inc runs the higher net margin — 0.6% vs -58.9%, a 59.4% gap on every dollar of revenue. On growth, Invesco posted the faster year-over-year revenue change (6.2% vs -3.0%). Invesco produced more free cash flow last quarter ($432.2M vs $9.1M). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs -3.2%).

ASGN Inc is a leading U.S.-headquartered professional services and workforce solutions provider. It specializes in supplying skilled talent and consulting services across high-growth segments including information technology, creative, digital, life sciences, and engineering, primarily serving enterprise clients across North America.

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

ASGN vs IVZ — Head-to-Head

Bigger by revenue
IVZ
IVZ
1.7× larger
IVZ
$1.7B
$970.0M
ASGN
Growing faster (revenue YoY)
IVZ
IVZ
+9.2% gap
IVZ
6.2%
-3.0%
ASGN
Higher net margin
ASGN
ASGN
59.4% more per $
ASGN
0.6%
-58.9%
IVZ
More free cash flow
IVZ
IVZ
$423.1M more FCF
IVZ
$432.2M
$9.1M
ASGN
Faster 2-yr revenue CAGR
IVZ
IVZ
Annualised
IVZ
7.1%
-3.2%
ASGN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ASGN
ASGN
IVZ
IVZ
Revenue
$970.0M
$1.7B
Net Profit
$5.5M
$-995.9M
Gross Margin
27.5%
Operating Margin
2.9%
-86.2%
Net Margin
0.6%
-58.9%
Revenue YoY
-3.0%
6.2%
Net Profit YoY
-73.7%
-575.8%
EPS (diluted)
$0.13
$-2.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASGN
ASGN
IVZ
IVZ
Q1 26
$970.0M
Q4 25
$980.1M
$1.7B
Q3 25
$1.0B
$1.6B
Q2 25
$1.0B
$1.5B
Q1 25
$968.3M
$1.5B
Q4 24
$985.0M
$1.6B
Q3 24
$1.0B
$1.5B
Q2 24
$1.0B
$1.5B
Net Profit
ASGN
ASGN
IVZ
IVZ
Q1 26
$5.5M
Q4 25
$25.2M
$-995.9M
Q3 25
$38.1M
$356.4M
Q2 25
$29.3M
$197.4M
Q1 25
$20.9M
$171.1M
Q4 24
$42.4M
$209.3M
Q3 24
$47.5M
$55.0M
Q2 24
$47.2M
$132.2M
Gross Margin
ASGN
ASGN
IVZ
IVZ
Q1 26
27.5%
Q4 25
28.9%
Q3 25
29.4%
Q2 25
28.7%
Q1 25
28.4%
Q4 24
29.0%
Q3 24
29.1%
Q2 24
29.1%
Operating Margin
ASGN
ASGN
IVZ
IVZ
Q1 26
2.9%
Q4 25
5.7%
-86.2%
Q3 25
6.7%
16.5%
Q2 25
5.8%
14.1%
Q1 25
4.8%
18.1%
Q4 24
7.5%
19.6%
Q3 24
7.7%
6.6%
Q2 24
7.8%
13.9%
Net Margin
ASGN
ASGN
IVZ
IVZ
Q1 26
0.6%
Q4 25
2.6%
-58.9%
Q3 25
3.8%
21.7%
Q2 25
2.9%
13.0%
Q1 25
2.2%
11.2%
Q4 24
4.3%
13.1%
Q3 24
4.6%
3.6%
Q2 24
4.6%
8.9%
EPS (diluted)
ASGN
ASGN
IVZ
IVZ
Q1 26
$0.13
Q4 25
$0.58
$-2.61
Q3 25
$0.87
$0.66
Q2 25
$0.67
$-0.03
Q1 25
$0.48
$0.38
Q4 24
$0.94
$0.46
Q3 24
$1.06
$0.12
Q2 24
$1.02
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASGN
ASGN
IVZ
IVZ
Cash + ST InvestmentsLiquidity on hand
$143.6M
$1.0B
Total DebtLower is stronger
$1.5B
$1.8B
Stockholders' EquityBook value
$1.8B
$12.2B
Total Assets
$4.0B
$27.1B
Debt / EquityLower = less leverage
0.82×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASGN
ASGN
IVZ
IVZ
Q1 26
$143.6M
Q4 25
$161.2M
$1.0B
Q3 25
$973.1M
Q2 25
$922.7M
Q1 25
$821.7M
Q4 24
$205.2M
$986.5M
Q3 24
$1.0B
Q2 24
$878.5M
Total Debt
ASGN
ASGN
IVZ
IVZ
Q1 26
$1.5B
Q4 25
$1.2B
$1.8B
Q3 25
$1.2B
$1.6B
Q2 25
$1.2B
$1.9B
Q1 25
$1.3B
$964.8M
Q4 24
$1.0B
$890.6M
Q3 24
$1.0B
$890.3M
Q2 24
$1.0B
$890.1M
Stockholders' Equity
ASGN
ASGN
IVZ
IVZ
Q1 26
$1.8B
Q4 25
$1.8B
$12.2B
Q3 25
$1.8B
$14.0B
Q2 25
$1.8B
$13.9B
Q1 25
$1.8B
$14.7B
Q4 24
$1.8B
$14.6B
Q3 24
$1.8B
$14.8B
Q2 24
$1.8B
$14.6B
Total Assets
ASGN
ASGN
IVZ
IVZ
Q1 26
$4.0B
Q4 25
$3.7B
$27.1B
Q3 25
$3.7B
$28.4B
Q2 25
$3.7B
$28.5B
Q1 25
$3.7B
$28.1B
Q4 24
$3.4B
$27.0B
Q3 24
$3.4B
$27.5B
Q2 24
$3.5B
$27.2B
Debt / Equity
ASGN
ASGN
IVZ
IVZ
Q1 26
0.82×
Q4 25
0.65×
0.15×
Q3 25
0.64×
0.12×
Q2 25
0.66×
0.14×
Q1 25
0.72×
0.07×
Q4 24
0.58×
0.06×
Q3 24
0.58×
0.06×
Q2 24
0.57×
0.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASGN
ASGN
IVZ
IVZ
Operating Cash FlowLast quarter
$455.8M
Free Cash FlowOCF − Capex
$9.1M
$432.2M
FCF MarginFCF / Revenue
0.9%
25.5%
Capex IntensityCapex / Revenue
1.0%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$290.6M
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASGN
ASGN
IVZ
IVZ
Q1 26
Q4 25
$102.3M
$455.8M
Q3 25
$83.9M
$606.2M
Q2 25
$124.9M
$547.9M
Q1 25
$16.8M
$-84.6M
Q4 24
$100.2M
$316.9M
Q3 24
$135.8M
$438.4M
Q2 24
$90.7M
$489.1M
Free Cash Flow
ASGN
ASGN
IVZ
IVZ
Q1 26
$9.1M
Q4 25
$93.7M
$432.2M
Q3 25
$72.0M
$586.4M
Q2 25
$115.8M
$530.4M
Q1 25
$6.6M
$-108.0M
Q4 24
$88.9M
$309.9M
Q3 24
$127.9M
$410.0M
Q2 24
$85.4M
$462.4M
FCF Margin
ASGN
ASGN
IVZ
IVZ
Q1 26
0.9%
Q4 25
9.6%
25.5%
Q3 25
7.1%
35.7%
Q2 25
11.3%
35.0%
Q1 25
0.7%
-7.1%
Q4 24
9.0%
19.5%
Q3 24
12.4%
27.1%
Q2 24
8.3%
31.2%
Capex Intensity
ASGN
ASGN
IVZ
IVZ
Q1 26
1.0%
Q4 25
0.9%
1.4%
Q3 25
1.2%
1.2%
Q2 25
0.9%
1.2%
Q1 25
1.1%
1.5%
Q4 24
1.1%
0.4%
Q3 24
0.8%
1.9%
Q2 24
0.5%
1.8%
Cash Conversion
ASGN
ASGN
IVZ
IVZ
Q1 26
Q4 25
4.06×
Q3 25
2.20×
1.70×
Q2 25
4.26×
2.78×
Q1 25
0.80×
-0.49×
Q4 24
2.36×
1.51×
Q3 24
2.86×
7.97×
Q2 24
1.92×
3.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASGN
ASGN

Segment breakdown not available.

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

Related Comparisons